AUTOLUS
Autolus Therapeutics is working on next-generation programmed T cell treatments for the treatment of cancer. The company's pipeline includes Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Autolus was established in 2014 by Tim Funnell and Martin Pule in London, England.
AUTOLUS
Social Links:
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2014-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.autolus.com
Total Employee:
251+
Status:
Active
Contact:
+44 (0)20 3829 6230
Email Addresses:
[email protected]
Total Funding:
1.13 B USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon SSL By Default Microsoft Exchange Online Microsoft Azure DNS ASP.NET IIS ASP.NET 4.0
Similar Organizations
Avilar Therapeutics
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Faron Pharmaceuticals
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Current Employees Featured
Founder
Stock Details
Investors List
Blackstone Group
Blackstone Group investment in Post-IPO Equity - Autolus
PPF Group
PPF Group investment in Post-IPO Equity - Autolus
4BIO Capital
4BIO Capital investment in Post-IPO Equity - Autolus
Syncona Partners LLP
Syncona Partners LLP investment in Series C - Autolus
UCLB
UCLB investment in Series C - Autolus
Nextech Invest
Nextech Invest investment in Series C - Autolus
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Autolus
Google Ventures
Google Ventures investment in Series C - Autolus
Arix Bioscience
Arix Bioscience investment in Series C - Autolus
Woodford Investment Management
Woodford Investment Management investment in Series C - Autolus
Official Site Inspections
http://www.autolus.com Semrush global rank: 3.16 M Semrush visits lastest month: 4.73 K
- Host name: 13.69.68.48
- IP address: 13.69.68.48
- Location: Amsterdam Netherlands
- Latitude: 52.3534
- Longitude: 4.9087
- Timezone: Europe/Amsterdam
- Postal: 1091
More informations about "Autolus"
About us - Autolus
Autolus is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London in 2014. Since its inception, the company has …See details»
Leadership | About us - Autolus
Alexander Swan serves as Chief Human Resources Officer. Alec joined Autolus prior to the IPO in 2018 as VP, Human Resources. Prior to that he was EMEA Head of Human Resources for …See details»
Autolus - Crunchbase Company Profile & Funding
Autolus Therapeutics is working on next-generation programmed T cell treatments for the treatment of cancer. The company's pipeline includes Obe …See details»
Home | AutolusAssist™
A Case Manager is ready to answer questions you may have about insurance, Autolus CAR T-cell treatment, and support resources throughout the CAR T-cell journey. (855) 288-5227. Provider …See details»
Autolus - Leadership Team - The Org
The Leadership Team at Autolus focuses on strategic decision-making and direction to advance the company's innovative approaches in cell programming and manufacturing for cancer …See details»
Autolus - The Org
Autolus utilises advanced cell programming and manufacturing technologies and we have established a development-stage pipeline of products for the treatment of haematological …See details»
Member profile: Autolus Ltd | BIA - bioindustry.org
Autolus Therapeutics plc (Nasdaq: AUTL) is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a …See details»
Autolus Therapeutics - LinkedIn
Autolus Therapeutics | 29,449 followers on LinkedIn. Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer | Autolus is a CAR T cell therapy company.See details»
AUTOLUS INC. Company Profile | Gaithersburg, MD | Competitors ...
Find company research, competitor information, contact details & financial data for AUTOLUS INC. of Gaithersburg, MD. Get the latest business insights from Dun & Bradstreet.See details»
Our history | About us - Autolus
Autolus is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London in 2014. Since its inception, the company has undergone rapid growth, systematically adding …See details»
Autolus - VentureRadar
Autolus is a leader in T cell programming technologies and believes its leadership will provide a competitive advantage as it looks to develop future generations of T cell therapies targeting …See details»
Autolus Company Profile - Office Locations, Competitors ... - Craft
Autolus Therapeutics is a biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. The Company is committed …See details»
Patients and Caregivers | AutolusAssist™
These organizations are independent from and not sponsored by Autolus. They are provided as a resource for patients and caregivers, but all program information is maintained by external …See details»
Mission, Vision & Core Values of Autolus – …
Nov 24, 2024 [cbm_blg_rlnkng]Autolus Mission, Vision & Core Values: Autolus is a leading clinical-stage biopharmaceutical company focused on pioneering the development of …See details»
Investor relations & Media | Autolus
Autolus is building a fully-integrated, next generation CAR T company. It is committed to the development and commercialization of obe-cel in r/r Adult ALL and is progressing …See details»
Autolus Announces Changes to Executive Leadership Team
Aug 10, 2019 Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced changes …See details»
Autolus Therapeutics Highlights Advancing Autoimmune
2 days ago Autolus presented updates on its development pipeline and plans for expansion in autoimmune diseases at an R&D investor event. ...See details»
Autolus - Funding, Financials, Valuation & Investors - Crunchbase
Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. …See details»
Autolus Therapeutics to Announce Q1 2025 Financial Results and …
3 days ago Autolus Therapeutics will announce Q1 2025 financial results on May 8, 2025, followed by a conference call. Quiver AI Summary. Autolus Therapeutics plc, a …See details»
Corporate governance | Investor relations & Media | Autolus
The Board of Directors of Autolus Therapeutics plc sets high standards for our employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is …See details»